{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Gastrointestinal epithelial barrier disorders",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_mesalamine",
          "name": "Mesalamine"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_budesonide",
          "name": "Budesonide"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_prednisone",
          "name": "Prednisone"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_azathioprine",
          "name": "Azathioprine"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_6_mercaptopurine",
          "name": "6-Mercaptopurine"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_infliximab",
          "name": "Infliximab"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_adalimumab",
          "name": "Adalimumab"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_ticagrelor",
          "name": "Ticagrelor"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_ustekinumab",
          "name": "Ustekinumab"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_vedolizumab",
          "name": "Vedolizumab"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_tofacitinib",
          "name": "Tofacitinib"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_rifaximin",
          "name": "Rifaximin"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_mesalamine",
          "type": "Drug",
          "label": "Mesalamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_budesonide",
          "type": "Drug",
          "label": "Budesonide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_prednisone",
          "type": "Drug",
          "label": "Prednisone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_6_mercaptopurine",
          "type": "Drug",
          "label": "6-Mercaptopurine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_infliximab",
          "type": "Drug",
          "label": "Infliximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ticagrelor",
          "type": "Drug",
          "label": "Ticagrelor",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ustekinumab",
          "type": "Drug",
          "label": "Ustekinumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_vedolizumab",
          "type": "Drug",
          "label": "Vedolizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tofacitinib",
          "type": "Drug",
          "label": "Tofacitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rifaximin",
          "type": "Drug",
          "label": "Rifaximin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_epithelial_cells",
          "type": "Target",
          "label": "Epithelial Cells",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_inflammatory_response",
          "type": "Pathway",
          "label": "Inflammatory Response",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_gastrointestinal_disorders",
          "type": "Disease",
          "label": "Gastrointestinal Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "phenotype_barrier_dysfunction",
          "type": "Phenotype",
          "label": "Barrier Dysfunction",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_mesalamine",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知靶向肠道上皮细胞"
        },
        {
          "source": "drug_budesonide",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "具有抗炎作用"
        },
        {
          "source": "drug_prednisone",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "类固醇类药物改善肠道损伤"
        },
        {
          "source": "drug_azathioprine",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "免疫抑制剂可以改善相关疾病"
        },
        {
          "source": "drug_6_mercaptopurine",
          "target": "target_epithelial_cells",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "与多种肠道疾病相关临床应用"
        },
        {
          "source": "drug_infliximab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "单克隆抗体调节炎症反应"
        },
        {
          "source": "drug_adalimumab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "单克隆抗体也能影响炎症"
        },
        {
          "source": "drug_ticagrelor",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "尽管主要用于心血管，但可能影响其他通路"
        },
        {
          "source": "drug_ustekinumab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "针对IL-12/23的作用"
        },
        {
          "source": "drug_vedolizumab",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "靶向肠道特异性强调"
        },
        {
          "source": "drug_tofacitinib",
          "target": "pathway_inflammatory_response",
          "relation": "modulates",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "JAK抑制剂在免疫过程中的潜在应用"
        },
        {
          "source": "drug_rifaximin",
          "target": "pathway_inflammatory_response",
          "relation": "involved_in",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "影响肠道微生物与炎症"
        },
        {
          "source": "target_epithelial_cells",
          "target": "phenotype_barrier_dysfunction",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "上皮细胞功能直接影响屏障功能"
        },
        {
          "source": "pathway_inflammatory_response",
          "target": "disease_gastrointestinal_disorders",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "与多种胃肠疾病相关的炎症通路"
        },
        {
          "source": "phenotype_barrier_dysfunction",
          "target": "disease_gastrointestinal_disorders",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "屏障功能障碍导致胃肠道疾病"
        },
        {
          "source": "drug_mesalamine",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "有效改善肠道上皮障碍相关疾病"
        },
        {
          "source": "drug_budesonide",
          "target": "H2",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床实践中常用于肠道疾病"
        },
        {
          "source": "drug_prednisone",
          "target": "H3",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "有效性通过临床观察得知"
        },
        {
          "source": "drug_azathioprine",
          "target": "H4",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "用药历史表明其对肠道疾病的影响"
        },
        {
          "source": "drug_6_mercaptopurine",
          "target": "H5",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "存在用于治疗溃疡性结肠炎等的依据"
        },
        {
          "source": "drug_infliximab",
          "target": "H6",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "众多临床试验支持其有效性"
        },
        {
          "source": "drug_adalimumab",
          "target": "H7",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "临床使用数据与疗效高度一致"
        },
        {
          "source": "drug_ustekinumab",
          "target": "H9",
          "relation": "supports",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "相关指引建议其用于治疗"
        },
        {
          "source": "drug_vedolizumab",
          "target": "H10",
          "relation": "supports",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对肠道特异性的临床证据支持"
        },
        {
          "source": "drug_tofacitinib",
          "target": "H11",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "存在潜在作用，但需更多研究"
        },
        {
          "source": "drug_rifaximin",
          "target": "H12",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "需要进一步验证其效果"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "多种药物通过影响肠道上皮细胞及炎症通路，能够改善胃肠道上皮屏障功能",
        "confidence": "high"
      }
    ],
    "assumptions": [
      "药物能够入血并达到作用靶点的程度"
    ],
    "uncertainties": [
      "部分药物的长期影响与效果尚需进一步研究"
    ],
    "next_focus_for_pi": [
      "考虑进一步确认药物的具体作用机制及长期效果"
    ]
  }
}